BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15038074)

  • 21. Identification of serum factor inducing ectodomain shedding of proHB-EGF and sStudies of noncleavable mutants of proHB-EGF.
    Hirata M; Umata T; Takahashi T; Ohnuma M; Miura Y; Iwamoto R; Mekada E
    Biochem Biophys Res Commun; 2001 May; 283(4):915-22. PubMed ID: 11350072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nardilysin enhances ectodomain shedding of heparin-binding epidermal growth factor-like growth factor through activation of tumor necrosis factor-alpha-converting enzyme.
    Nishi E; Hiraoka Y; Yoshida K; Okawa K; Kita T
    J Biol Chem; 2006 Oct; 281(41):31164-72. PubMed ID: 16923819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual intracellular signaling by proteolytic cleavage of membrane-anchored heparin-binding EGF-like growth factor.
    Nanba D; Higashiyama S
    Cytokine Growth Factor Rev; 2004 Feb; 15(1):13-9. PubMed ID: 14746810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin-induced ectodomain shedding of heparin-binding epidermal growth factor-like growth factor in adipocytes in vitro.
    Yamamoto T; Suganami T; Kiso-Narita M; Scherle PA; Kamei Y; Isobe M; Higashiyama S; Ogawa Y
    Obesity (Silver Spring); 2010 Oct; 18(10):1888-94. PubMed ID: 20111015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lysophosphatidic acid regulates murine blastocyst development by transactivation of receptors for heparin-binding EGF-like growth factor.
    Liu Z; Armant DR
    Exp Cell Res; 2004 Jun; 296(2):317-26. PubMed ID: 15149861
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ADAM-mediated ectodomain shedding of HB-EGF in receptor cross-talk.
    Higashiyama S; Nanba D
    Biochim Biophys Acta; 2005 Aug; 1751(1):110-7. PubMed ID: 16054021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ectodomain shedding of membrane-anchored heparin-binding EGF like growth factor and subcellular localization of the C-terminal fragment in the cell cycle.
    Toki F; Nanba D; Matsuura N; Higashiyama S
    J Cell Physiol; 2005 Mar; 202(3):839-48. PubMed ID: 15389565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of membrane-bound heparin-binding epidermal growth factor-like growth factor (HB-EGF) in renal epithelial cell branching.
    Takemura T; Hino S; Okada M; Murata Y; Yanagida H; Ikeda M; Yoshioka K; Harris RC
    Kidney Int; 2002 Jun; 61(6):1968-79. PubMed ID: 12028437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Membrane-anchored heparin-binding EGF-like growth factor processing by ADAM12 in cardiac hypertrophy].
    Higashiyama S
    Nihon Rinsho; 2003 May; 61(5):767-75. PubMed ID: 12755001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lysophosphatidic acid stimulates epidermal growth factor-family ectodomain shedding and paracrine signaling from human lung fibroblasts.
    Shiomi T; Boudreault F; Padem N; Higashiyama S; Drazen JM; Tschumperlin DJ
    Wound Repair Regen; 2011; 19(2):229-40. PubMed ID: 21362091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insufficiency of pro-heparin-binding epidermal growth factor-like growth factor shedding enhances hypoxic cell death in H9c2 cardiomyoblasts via the activation of caspase-3 and c-Jun N-terminal kinase.
    Uetani T; Nakayama H; Okayama H; Okura T; Higaki J; Inoue H; Higashiyama S
    J Biol Chem; 2009 May; 284(18):12399-409. PubMed ID: 19193634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transactivation of epidermal growth factor receptor after heparin-binding epidermal growth factor-like growth factor shedding in the migration of prostate cancer cells promoted by bombesin.
    Madarame J; Higashiyama S; Kiyota H; Madachi A; Toki F; Shimomura T; Tani N; Oishi Y; Matsuura N
    Prostate; 2003 Nov; 57(3):187-95. PubMed ID: 14518027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of mesangial cell hexokinase activity and expression by heparin-binding epidermal growth factor-like growth factor: epidermal growth factors and phorbol esters increase glucose metabolism via a common mechanism involving classic mitogen-activated protein kinase pathway activation and induction of hexokinase II expression.
    Robey RB; Ma J; Santos AV; Noboa OA; Coy PE; Bryson JM
    J Biol Chem; 2002 Apr; 277(17):14370-8. PubMed ID: 11782486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pharmacological role of HB-EGF shedding by angiotensin II in cardiomyocytes].
    Takashima S
    Nihon Yakurigaku Zasshi; 2004 Aug; 124(2):69-75. PubMed ID: 15277724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heparin blockade of thrombin-induced smooth muscle cell migration involves inhibition of epidermal growth factor (EGF) receptor transactivation by heparin-binding EGF-like growth factor.
    Kalmes A; Vesti BR; Daum G; Abraham JA; Clowes AW
    Circ Res; 2000 Jul; 87(2):92-8. PubMed ID: 10903991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PKCĪ± and PKCĪ“ regulate ADAM17-mediated ectodomain shedding of heparin binding-EGF through separate pathways.
    Kveiborg M; Instrell R; Rowlands C; Howell M; Parker PJ
    PLoS One; 2011 Feb; 6(2):e17168. PubMed ID: 21386996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy.
    Asakura M; Kitakaze M; Takashima S; Liao Y; Ishikura F; Yoshinaka T; Ohmoto H; Node K; Yoshino K; Ishiguro H; Asanuma H; Sanada S; Matsumura Y; Takeda H; Beppu S; Tada M; Hori M; Higashiyama S
    Nat Med; 2002 Jan; 8(1):35-40. PubMed ID: 11786904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Importance of the major extracellular domain of CD9 and the epidermal growth factor (EGF)-like domain of heparin-binding EGF-like growth factor for up-regulation of binding and activity.
    Nakamura K; Mitamura T; Takahashi T; Kobayashi T; Mekada E
    J Biol Chem; 2000 Jun; 275(24):18284-90. PubMed ID: 10749879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation.
    Fujiyama S; Matsubara H; Nozawa Y; Maruyama K; Mori Y; Tsutsumi Y; Masaki H; Uchiyama Y; Koyama Y; Nose A; Iba O; Tateishi E; Ogata N; Jyo N; Higashiyama S; Iwasaka T
    Circ Res; 2001 Jan; 88(1):22-9. PubMed ID: 11139469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ectodomain cleavage of the EGF ligands HB-EGF, neuregulin1-beta, and TGF-alpha is specifically triggered by different stimuli and involves different PKC isoenzymes.
    Herrlich A; Klinman E; Fu J; Sadegh C; Lodish H
    FASEB J; 2008 Dec; 22(12):4281-95. PubMed ID: 18757500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.